Medical Director and Chief Pathologist, PhenoPath Laboratories, Seattle, WA
Pathology
Dr. Allen M. Gown, MD
|
|
Give Review
Allen Gown practices Pathology. He went to medical school at Albert Einstein College of Medicine of Yeshiva University. He has 1 awards "Super Doctor". Allen Gown is a published MD. He published 59 publications, including: 'BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas.' Allen M. Gown accepts all Medicare patients.
Publications
- BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas.
- Evaluation of contemporary prostate and urothelial lineage biomarkers in a consecutive cohort of poorly differentiated bladder neck carcinomas.
- PAX8 Expression in Uterine Malignant Mesodermal Mixed Tumor (Carcinosarcoma).
- p16 FISH Deletion in Surface Epithelial Mesothelial Proliferations Is Predictive of Underlying Invasive Mesothelioma.
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group.
- Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases.
- Immunohistochemical Characterization of Squamous Differentiation and Morular Metaplasia in Uterine Endometrioid Adenocarcinoma.
- Determining True HER2 Gene Status in Breast Cancers With Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2 Targeted Therapy.
- The Knowns and the Unknowns in HER2 Testing in Breast Cancer.
- Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology.
- Fixation time does not affect expression of HER2/neu.
- Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: A clinicopathologic study of 41 cases: detailed assessment of morphology and risk strati...
- Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
- Thyroid transcription factor-1 expression in breast carcinomas.
- Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription po...
- Diagnostic utility of galectin-3 in thyroid cancer.
- Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.
- Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) ...
- Tweaking and nudging toward improved-IHC quality.
- Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
- Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
- Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.
- High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system.
- Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.
- Current issues in ER and HER2 testing by IHC in breast cancer.
- Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism.
- Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms.
- Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors.
- Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that...
- p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related en...
- Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
- Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predic...
- Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation ...
- Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution i...
- Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
- Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal ...
- Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases.
- Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive.
- Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probe.
- Do we need two more mesothelial markers?
- Vaginal lymphatic channel location and its implication for intracavitary brachytherapy radiation treatment.
- Nuclear beta-catenin in mesenchymal tumors.
- Mixed carcinoid and adenocarcinoma of the appendix: report of 4 cases with immunohistochemical studies and a review of the literature.
- Testing for epidermal growth factor receptor in lung cancer: have we learned anything from HER-2 testing?
- Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
- Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin.
- HER-2 testing in breast cancer using parallel tissue-based methods.
- Accuracy and precision in HER2/neu testing in breast cancer: are we there yet?
- Unmasking the mysteries of antigen or epitope retrieval and formalin fixation.
- Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis.
- CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.
- Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
- Immunohistochemical markers of melanocytic tumors.
- Testing for HER-2/neu in breast cancer: is fluorescence in situ hybridization superior in predicting outcome?
- Pharmacologically regulated in vivo selection in a large animal.
- Controversies and guidelines in tissue-based HER-2/neu testing in breast cancer.
- Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3.
- Differential Expression of Myoepithelial Markers in Salivary, Sweat and Mammary Glands.
Schools
Albert Einstein College of Medicine of Yeshiva University
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
Awards
- Super Doctor
Education
-
University of Washington -
Albert Einstein College of Medicine of Yeshiva University
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689779134 |
| Last Name Of The Provider | GOWN |
| First Name Of The Provider | ALLEN |
| View All |
Similar Doctors
|
|
Dr. S N. Agoff, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hejin P. Hahn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles E. Alpers, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David H. Dail, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen Tsuchiya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roberto F. Nicosia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Laflamme, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas H. Norwood, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kelly D. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nan P. Wang, MD |
|
|
Dr. Glenna C. Burmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa K. Koch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy W. Jacobs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Alexander C. Ritchie, MB CHB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mara H. Rendi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam J. Saenz, MD
This Doctor is OpenDoctor Recommended.
|